Literature DB >> 18391593

Competing causes of death for women with breast cancer and change over time from 1975 to 2003.

Xianglin L Du1, Erin E Fox, Dejian Lai.   

Abstract

This study was to determine whether the proportion of death due to breast cancer changed over time in different cohorts of women diagnosed with breast cancer. We identified 316,149 women with breast cancer at age 20 or older during 1975-2003 from the Surveillance, Epidemiology, and End Results 9 tumor registries in the United States. Logistic regression models were used to assess the effects of time period on the likelihood of dying because of breast cancer as underlying cause of death, adjusting for other factors. Overall, underlying cause of death was 52.8% due to breast cancer, 17.8% due to heart disease, and 4.9% due to stroke. Percentage of death due to breast cancer did not change significantly from 1975 to 2003 in those who died < 12 months after diagnosis, but decreased significantly in women who died between 1 and 15 years. Risk of death due to breast cancer in women diagnosed during 1995-1998 was significantly lower than those in 1975-1979 (odds ratio = 0.79, 95% confidence interval = 0.70-0.89), after adjusting for age, race, ethnicity, and tumor stage. Percentage of death due to breast cancer decreased significantly with age from 87.5% in women < 40% to 30.7% in those 80 or older, which was not significantly affected by year of diagnosis. Proportion of death due to breast cancer increased with advanced tumor stage and was similar in various racial/ethnic groups of population. The findings demonstrated that the impact of breast cancer on overall death was reduced after 1 year of diagnosis, but suggested the need for continued cancer surveillance.

Entities:  

Mesh:

Year:  2008        PMID: 18391593      PMCID: PMC2570158          DOI: 10.1097/COC.0b013e318142c865

Source DB:  PubMed          Journal:  Am J Clin Oncol        ISSN: 0277-3732            Impact factor:   2.339


  34 in total

1.  Re: Tumor characteristics and clinical outcome of elderly women with breast cancer.

Authors:  M Basche; T Byers
Journal:  J Natl Cancer Inst       Date:  2001-01-03       Impact factor: 13.506

2.  Problems with proper completion and accuracy of the cause-of-death statement.

Authors:  A E Smith Sehdev; G M Hutchins
Journal:  Arch Intern Med       Date:  2001-01-22

Review 3.  Side effects of chemotherapy and combined chemohormonal therapy in women with early-stage breast cancer.

Authors:  A H Partridge; H J Burstein; E P Winer
Journal:  J Natl Cancer Inst Monogr       Date:  2001

Review 4.  Side effects of adjuvant treatment of breast cancer.

Authors:  C L Shapiro; A Recht
Journal:  N Engl J Med       Date:  2001-06-28       Impact factor: 91.245

5.  Favourable and unfavourable effects on long-term survival of radiotherapy for early breast cancer: an overview of the randomised trials. Early Breast Cancer Trialists' Collaborative Group.

Authors: 
Journal:  Lancet       Date:  2000-05-20       Impact factor: 79.321

6.  Tumor characteristics and clinical outcome of elderly women with breast cancer.

Authors:  S G Diab; R M Elledge; G M Clark
Journal:  J Natl Cancer Inst       Date:  2000-04-05       Impact factor: 13.506

7.  The relative risks and etiologic fractions of different causes of death and disease attributable to alcohol, tobacco and illicit drug use in Canada.

Authors:  E Single; J Rehm; L Robson; M V Truong
Journal:  CMAJ       Date:  2000-06-13       Impact factor: 8.262

8.  Contribution of major diseases to disparities in mortality.

Authors:  Mitchell D Wong; Martin F Shapiro; W John Boscardin; Susan L Ettner
Journal:  N Engl J Med       Date:  2002-11-14       Impact factor: 91.245

9.  Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer.

Authors:  Bernard Fisher; Stewart Anderson; John Bryant; Richard G Margolese; Melvin Deutsch; Edwin R Fisher; Jong-Hyeon Jeong; Norman Wolmark
Journal:  N Engl J Med       Date:  2002-10-17       Impact factor: 91.245

10.  Twenty-year follow-up of a randomized study comparing breast-conserving surgery with radical mastectomy for early breast cancer.

Authors:  Umberto Veronesi; Natale Cascinelli; Luigi Mariani; Marco Greco; Roberto Saccozzi; Alberto Luini; Marisel Aguilar; Ettore Marubini
Journal:  N Engl J Med       Date:  2002-10-17       Impact factor: 91.245

View more
  25 in total

1.  Assessing non-cancer-related health status of US cancer patients: other-cause survival and comorbidity prevalence.

Authors:  Hyunsoon Cho; Angela B Mariotto; Bhupinder S Mann; Carrie N Klabunde; Eric J Feuer
Journal:  Am J Epidemiol       Date:  2013-07-03       Impact factor: 4.897

Review 2.  The effects of exercise on cardiovascular outcomes before, during, and after treatment for breast cancer.

Authors:  Kathleen M Sturgeon; Bonnie Ky; Joseph R Libonati; Kathryn H Schmitz
Journal:  Breast Cancer Res Treat       Date:  2013-12-14       Impact factor: 4.872

3.  Preoperative delays in the US Medicare population with breast cancer.

Authors:  Richard J Bleicher; Karen Ruth; Elin R Sigurdson; Eric Ross; Yu-Ning Wong; Sameer A Patel; Marcia Boraas; Neal S Topham; Brian L Egleston
Journal:  J Clin Oncol       Date:  2012-11-19       Impact factor: 44.544

4.  Development and Validation of Endovascular Chemotherapy Filter Device for Removing High-Dose Doxorubicin: Preclinical Study.

Authors:  Anand S Patel; Maythem Saeed; Erin J Yee; Jeffrey Yang; Gregory J Lam; Aaron D Losey; Prasheel V Lillaney; Bradford Thorne; Albert K Chin; Sheena Malik; Mark W Wilson; Xi C Chen; Nitash P Balsara; Steven W Hetts
Journal:  J Med Device       Date:  2014-08-19       Impact factor: 0.582

Review 5.  Novel treatment strategies for brain tumors and metastases.

Authors:  Salma E El-Habashy; Alaa M Nazief; Chris E Adkins; Ming Ming Wen; Amal H El-Kamel; Ahmed M Hamdan; Amira S Hanafy; Tori O Terrell; Afroz S Mohammad; Paul R Lockman; Mohamed Ismail Nounou
Journal:  Pharm Pat Anal       Date:  2014-05

6.  Low to moderate dose anthracycline-based chemotherapy is associated with early noninvasive imaging evidence of subclinical cardiovascular disease.

Authors:  Brandon C Drafts; Katie M Twomley; Ralph D'Agostino; Julia Lawrence; Nancy Avis; Leslie R Ellis; Vinay Thohan; Jennifer Jordan; Susan A Melin; Frank M Torti; William C Little; Craig A Hamilton; W Gregory Hundley
Journal:  JACC Cardiovasc Imaging       Date:  2013-05-01

7.  Weekly doxorubicin increases coronary arteriolar wall and adventitial thickness.

Authors:  Delrae M Eckman; R Brandon Stacey; Robert Rowe; Ralph D'Agostino; Nancy D Kock; David C Sane; Frank M Torti; Joseph Yeboah; Susan Workman; Kimberly S Lane; W Gregory Hundley
Journal:  PLoS One       Date:  2013-02-21       Impact factor: 3.240

Review 8.  Understanding cardiovascular injury after treatment for cancer: an overview of current uses and future directions of cardiovascular magnetic resonance.

Authors:  Sujethra Vasu; W Gregory Hundley
Journal:  J Cardiovasc Magn Reson       Date:  2013-07-31       Impact factor: 5.364

9.  Mycogenic Synthesis of Extracellular Zinc Oxide Nanoparticles from Xylaria acuta and Its Nanoantibiotic Potential.

Authors:  Basavaraju Sumanth; Thimappa Ramachandrappa Lakshmeesha; Chowdappa Srinivas; Mohammad Azam Ansari; Mohammad A Alzohairy; Arakere Chunchegowda Udayashankar; Balagangadharaswamy Shobha; Siddapura Ramachandrappa Niranjana; Ahmad Almatroudi
Journal:  Int J Nanomedicine       Date:  2020-11-02

10.  Pharmacy deserts and patients with breast cancer receipt of influenza vaccines.

Authors:  Joan M Neuner; Yuhong Zhou; Nicole Fergestrom; Aaron Winn; Liliana Pezzin; Purushottam W Laud; Kirsten Beyer
Journal:  J Am Pharm Assoc (2003)       Date:  2021-07-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.